{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:08Z","timestamp":1740149828441,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12328-023-01822-w","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:01:26Z","timestamp":1689102086000},"page":"663-667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroendocrine carcinoma of the small intestine diagnosed as a result of paraneoplastic neurological syndrome"],"prefix":"10.1007","volume":"16","author":[{"given":"Kei","family":"Nakazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-4690","authenticated-orcid":false,"given":"Yuki","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Kakimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuaki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"1822_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/00019052-199812000-00004","volume":"11","author":"J Rees","year":"1998","unstructured":"Rees J. Paraneoplastic syndromes. Curr Opin Neurol. 1998;11:633\u20137.","journal-title":"Curr Opin Neurol"},{"key":"1822_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S1474-4422(02)00135-7","volume":"1","author":"R Voltz","year":"2002","unstructured":"Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol. 2002;1:294\u2013305.","journal-title":"Lancet Neurol"},{"key":"1822_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0065-2423(07)44005-7","volume":"44","author":"A Storstein","year":"2007","unstructured":"Storstein A, Vedeler CA. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects. Adv Clin Chem. 2007;44:143\u201385.","journal-title":"Adv Clin Chem"},{"key":"1822_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1055\/s-2004-861540","volume":"24","author":"L Bataller","year":"2004","unstructured":"Bataller L, Dalmau JO. Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. Semin Neurol. 2004;24:461\u201371.","journal-title":"Semin Neurol"},{"key":"1822_CR5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","volume":"13","author":"CA Vedeler","year":"2006","unstructured":"Vedeler CA, Antoine JC, Giometto B, et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006;13:682\u201390.","journal-title":"Eur J Neurol"},{"key":"1822_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00535-009-0194-8","volume":"45","author":"T Ito","year":"2010","unstructured":"Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol. 2010;45:234\u201343.","journal-title":"J Gastroenterol"},{"key":"1822_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1677\/ERC-10-0152","volume":"17","author":"MB Niederle","year":"2010","unstructured":"Niederle MB, Hackl M, Kaserer K, et al. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer. 2010;17:909\u201318.","journal-title":"Endocr Relat Cancer"},{"key":"1822_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000335629","volume":"95","author":"UF Pape","year":"2012","unstructured":"Pape UF, Perren A, Niederle B, et al. ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno\u2013ileum and the appendix including goblet cell carcinomas. Neuroendocrinology. 2012;95:135\u201356.","journal-title":"Neuroendocrinology"},{"key":"1822_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1822_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.anndiagpath.2017.04.005","volume":"29","author":"JY Kim","year":"2017","unstructured":"Kim JY, Hong SM, Ro JY. Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol. 2017;29:11\u20136.","journal-title":"Ann Diagn Pathol"},{"key":"1822_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11940-003-0023-y","volume":"5","author":"MR Rosenfeld","year":"2003","unstructured":"Rosenfeld MR, Dalmau J. Current therapies for paraneoplastic neurologic syndromes. Curr Treat Options Neurol. 2003;5:69\u201377.","journal-title":"Curr Treat Options Neurol"},{"key":"1822_CR12","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0022-3476(06)80167-8","volume":"125","author":"PS Koh","year":"1994","unstructured":"Koh PS, Raffensperger JG, Berry S, et al. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr. 1994;125:712\u20136.","journal-title":"J Pediatr"},{"issue":"Suppl 5","key":"1822_CR13","doi-asserted-by":"publisher","first-page":"V33","DOI":"10.1007\/s00415-006-5005-z","volume":"253","author":"R Voltz","year":"2006","unstructured":"Voltz R. Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes. J Neurol. 2006;253(Suppl 5):V33\u20138.","journal-title":"J Neurol"},{"key":"1822_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s004150050350","volume":"246","author":"F Blaes","year":"1999","unstructured":"Blaes F, Strittmatter M, Merkelbach S, et al. Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders. J Neurol. 1999;246:299\u2013303.","journal-title":"J Neurol"},{"key":"1822_CR15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","volume":"124","author":"F Graus","year":"2001","unstructured":"Graus F, Keime-Guibert F, Re\u00f1e R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138\u201348.","journal-title":"Brain"},{"key":"1822_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1572-0241.2001.03454.x","volume":"96","author":"HR Lee","year":"2001","unstructured":"Lee HR, Lennon VA, Camilleri M, et al. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol. 2001;96:373\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1822_CR17","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","volume":"50","author":"S Vernino","year":"1998","unstructured":"Vernino S, Adamski J, Kryzer TJ, et al. Neuronal nicotinic Ach receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology. 1998;50:1806\u201313.","journal-title":"Neurology"},{"key":"1822_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1634\/theoncologist.11-3-292","volume":"11","author":"JW de Beukelaar","year":"2006","unstructured":"de Beukelaar JW, Sillevis Smitt PA. Managing paraneoplastic neurological disorders. Oncologist. 2006;11:292\u2013305.","journal-title":"Oncologist"},{"key":"1822_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091\u20138.","journal-title":"Lancet Neurol"},{"key":"1822_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s00415-008-0845-3","volume":"255","author":"S Jarius","year":"2008","unstructured":"Jarius S, Hoffmann LA, Stich O, et al. Relative frequency of VGKC and \u2018classical\u2019 paraneoplastic antibodies in patients with limbic encephalitis. J Neurol. 2008;255:1100\u20131.","journal-title":"J Neurol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01822-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-023-01822-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01822-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T15:24:40Z","timestamp":1695914680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-023-01822-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1007\/s12328-023-01822-w","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"14 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was provided by the ethical committee of the institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures performed in this article involving human participants were conducted in accordance with the ethical standards of institutional and\/or national research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from the patient prior to all medical procedures.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}